These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17236297)

  • 1. IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.
    Cojocaru IM; Cojocaru M; Burcin C
    Rom J Intern Med; 2006; 44(2):165-70. PubMed ID: 17236297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.
    Zhao D; Ogawa H; Wang X; Cameron GS; Baty DE; Dlott JS; Triplett DA
    Am J Clin Pathol; 2001 Nov; 116(5):760-7. PubMed ID: 11710695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
    Lopez LR; Hurley BL; Simpson DF; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.
    Soltesz P; Veres K; Laczik R; Der H; Csipo I; Timar O; Szomjak E; Szegedi G; Szodoray P
    Thromb Haemost; 2007 Aug; 98(2):413-9. PubMed ID: 17721625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
    Radulescu L; Stancu C; Antohe F
    Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies against low density oxidized lipoproteins in type 2 diabetics].
    Malícková K; Skrha J; Janatková I; Vanková Z; Fucíková T
    Epidemiol Mikrobiol Imunol; 2004 Aug; 53(3):131-5. PubMed ID: 15524272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of metabolic control on oxidized low-density lipoprotein antibodies in children and adolescents with type 1 diabetes mellitus.
    Kara C; Cetinkaya S; Sezgin N; Kinik ST
    Pediatr Diabetes; 2008 Feb; 9(1):17-22. PubMed ID: 18211632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against oxidized LDL correlate with serum concentrations of ceruloplasmin in patients with cardiovascular disease.
    Awadallah SM; Hamad M; Jbarah I; Salem NM; Mubarak MS
    Clin Chim Acta; 2006 Mar; 365(1-2):330-6. PubMed ID: 16274685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
    Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
    Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.
    Lourida ES; Georgiadis AN; Papavasiliou EC; Papathanasiou AI; Drosos AA; Tselepis AD
    Arthritis Res Ther; 2007; 9(1):R19. PubMed ID: 17326817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease.
    Kankaanpää J; Turunen SP; Moilanen V; Hörkkö S; Remes AM
    Neurobiol Dis; 2009 Mar; 33(3):467-72. PubMed ID: 19130885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.
    Meisinger C; Baumert J; Khuseyinova N; Loewel H; Koenig W
    Circulation; 2005 Aug; 112(5):651-7. PubMed ID: 16043640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome?
    Bećarevic M; Andrejević S; Bonaci-Nikolić B; Obradović I; Miljić P; Majkić-Singh N
    Clin Lab; 2005; 51(5-6):279-83. PubMed ID: 15991801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis.
    Kobayashi K; Lopez LR; Shoenfeld Y; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.